Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment

PDF) How well does the Canadian Hemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with hemophilia?

Health Canada Has Now Authorized ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] in Pediatrics for Treatment of Children Under 12 with Hemophilia A[1]

PedsQL Publications, PDF, Chronic Fatigue Syndrome

Influvac® use in children

New hemophilia guidelines introduced at WFH Virtual Summit 2020 – Canadian Hemophilia Society

Therapeutic interchange in hemophilia aupdated

PDF) The impact of extended half‐life factor concentrates on

Publications Healthy Active Living and Obesity Research Group

International cross‐cultural validation study of the Canadian

PedsQL Publications, PDF, Chronic Fatigue Syndrome

Canadian Hemophilia Society

PDF) Impact of prophylaxis on health-related quality of life of

Validation of the pedHALshort and HALshort in Dutch children and

Women and girls with hemophilia - eLearning Platform

David Page: Rare Disease Day 2016 Conference